Literature DB >> 18620865

Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model.

Kwang Ree Cho1, Jae-Sung Choi, Woong Hahn, Dong Sik Kim, Jin Sik Park, Dong Soo Lee, Ki-Bong Kim.   

Abstract

OBJECTIVE: We evaluated the potency of therapeutic angiogenesis using intramyocardial injection of naked DNA expressing two isoforms of hepatocyte growth factor (pCK-HGF-X7) in a porcine myocardial infarction model.
METHODS: Four weeks after left anterior descending coronary artery ligation, 14 pigs were allocated to pCK-Null (negative control, n=7) or pCK-HGF-X7 (n=7) treatment groups. Gated myocardial single photon emission computed tomography was performed 4 and 8 weeks following coronary ligation. The effect of pCK-HGF-X7 on capillary density in the gene-injected myocardium was examined by histological analysis using alkaline phosphatase staining.
RESULTS: Segmental myocardial perfusion of the underperfused area (< or =70%) from coronary ligation increased in the pCK-HGF-X7 group (p=0.051), without significant differences in changes over time between the two groups (p=0.54). Systolic wall thickening (p=0.001), left ventricular end-diastolic (p=0.045) and end-systolic volumes (p=0.009), and left ventricular ejection fraction (p=0.041) changed in both groups without significant differences in changes over time between the two groups. The increase in the left stoke volume was higher in the pCK-HGF-X7 group than in the pCK-Null group (p=0.008). Histological analysis showed that capillary density was significantly higher in the pCK-HGF-X7 group than the pCK-Null group (p<0.001).
CONCLUSION: Intramyocardial injection of pCK-HGF-X7 induced significant angiogenesis at infarct-border zone, and increased the left ventricular stroke volume probably caused by reverse remodeling process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620865     DOI: 10.1016/j.ejcts.2008.05.045

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

1.  Hepatocyte growth factor gene-modified bone marrow-derived mesenchymal stem cells transplantation promotes angiogenesis in a rat model of hindlimb ischemia.

Authors:  Guan-Hua Su; Yu-Fei Sun; Yong-Xin Lu; Xin-Xin Shuai; Yu-Hua Liao; Qi-Yun Liu; Jun Han; Ping Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

2.  Cardiovascular magnetic resonance imaging in delivering and evaluating the efficacy of hepatocyte growth factor gene in chronic infarct scar.

Authors:  Maythem Saeed; David Saloner; Loi Do; Mark Wilson; Alastair Martin
Journal:  Cardiovasc Revasc Med       Date:  2010-10-20

Review 3.  Gene therapy for ischemic heart disease.

Authors:  Madhav Lavu; Susheel Gundewar; David J Lefer
Journal:  J Mol Cell Cardiol       Date:  2010-06-26       Impact factor: 5.000

4.  Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy.

Authors:  Senda Ajroud-Driss; Mark Christiansen; Jeffrey A Allen; John A Kessler
Journal:  Mol Ther       Date:  2013-04-23       Impact factor: 11.454

5.  Degradable acetalated dextran microparticles for tunable release of an engineered hepatocyte growth factor fragment.

Authors:  Sophia L Suarez; Adam Muñoz; Aaron Mitchell; Rebecca L Braden; Colin Luo; Jennifer R Cochran; Adah Almutairi; Karen L Christman
Journal:  ACS Biomater Sci Eng       Date:  2015-12-14

Review 6.  Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery.

Authors:  Adam G Berger; Jonathan J Chou; Paula T Hammond
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-07-07       Impact factor: 4.947

7.  Gene therapy using hepatocyte growth factor expressing adenovirus improves skin flap survival in a rat model.

Authors:  Dong Kyun Rah; In Sik Yun; Chae-Ok Yun; Sae Bin Lee; Won Jai Lee
Journal:  J Korean Med Sci       Date:  2014-11-21       Impact factor: 2.153

8.  Involvement of S1P1 receptor pathway in angiogenic effects of a novel adenosine-like nucleic acid analog COA-Cl in cultured human vascular endothelial cells.

Authors:  Junsuke Igarashi; Takeshi Hashimoto; Yasuo Kubota; Kazuyo Shoji; Tokumi Maruyama; Norikazu Sakakibara; Yoh Takuwa; Yoshihiro Ujihara; Yuki Katanosaka; Satoshi Mohri; Keiji Naruse; Tetsuo Yamashita; Ryuji Okamoto; Katsuya Hirano; Hiroaki Kosaka; Maki Takata; Ryoji Konishi; Ikuko Tsukamoto
Journal:  Pharmacol Res Perspect       Date:  2014-08-06

9.  Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model.

Authors:  Boram Nho; Junghun Lee; Junsub Lee; Kyeong Ryang Ko; Sung Joong Lee; Sunyoung Kim
Journal:  FASEB J       Date:  2018-04-16       Impact factor: 5.191

10.  Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats.

Authors:  Apoorva S Salimath; Edward A Phelps; Archana V Boopathy; Pao-lin Che; Milton Brown; Andrés J García; Michael E Davis
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.